background
coleth
synthet
lethal
document
genet
situat
two
separ
nonleth
mutat
becom
lethal
combin
one
genom
mutat
call
synthet
lethal
sl
coleth
like
invari
posit
sl
set
sl
link
coupl
choic
target
drug
design
fastescap
rna
virus
mutat
viral
escap
loss
affin
drug
may
induc
synthet
lethal
amino
acid
sequenc
align
hiv
proteas
detect
potenti
sl
coupl
potenti
sl
set
invari
posit
structur
protein
focus
one
close
access
protein
surfac
possibl
bind
put
drug
align
hiv
proteas
amino
acid
sequenc
identifi
potenti
sl
coupl
invari
posit
appli
distanc
access
filter
three
candid
drug
design
target
respect
flap
cantilev
fulcrum
amino
acid
posit
found
conclus
three
replicationcrit
target
locat
outsid
activ
site
key
antiescap
strategi
inde
biolog
evid
show
target
posit
perform
essenti
biolog
function
mutat
variat
escap
antivir
medic
could
lethal
thu
limit
apparit
drugresist
strain
background
rna
virus
alon
includ
differ
human
pathogen
agent
newli
emerg
diseas
recent
concern
actual
fear
pandem
sar
avian
flu
swine
flu
virus
rais
challeng
quickli
come
solut
worldwid
million
influenza
case
occur
year
million
peopl
carri
hcv
million
hiv
rna
virus
gener
high
mutat
rate
use
polymeras
find
fix
mistak
therefor
unabl
conduct
genom
repair
damag
genet
materi
select
pressur
errorpron
replic
confer
drug
resist
sinc
aid
appear
mani
new
drug
creat
use
rna
virus
turn
readili
evolv
drugresist
strain
predict
process
unpreced
public
health
issu
hiv
mutant
strain
escap
antivir
compound
extens
document
one
influenza
main
treatment
tamiflu
quickli
escap
influenza
strain
spread
surprisingli
fast
across
planet
becom
clearer
futur
antivir
strategi
address
issu
outset
aggress
strive
prevent
viral
escap
deal
sever
direct
explor
sinc
decad
structur
resist
protein
second
gener
drug
bind
resist
protein
drug
target
polymorph
analysi
order
defin
super
drug
definit
new
target
protein
backbon
dimer
protein
monom
order
block
dimeris
overal
although
individu
case
solut
found
gener
solut
emerg
yet
document
drug
resist
due
least
one
mutat
amino
acid
research
recommend
invari
viral
amino
acid
target
futur
new
drug
rational
mutat
invari
posit
alway
damag
critic
biolog
function
result
nonrepl
virus
exempl
zanamivir
broad
inhibitor
neuraminidas
influenza
glycoprotein
probabl
interact
invari
amino
acid
insid
enzym
activ
site
ceccherini
et
al
identifi
new
conserv
residu
hiv
proteas
revers
transcriptas
integras
map
protein
structur
help
design
new
structurebas
escaperesist
inhibitor
unfortun
sometim
invari
posit
constitut
proper
dock
site
drug
exampl
hiv
proteas
amino
acid
variabl
effort
gather
enough
replicativitycrit
amino
acid
possibl
dock
site
propos
also
target
synthet
lethal
sl
coleth
synthet
lethal
lethal
result
two
individu
surviv
mutat
copres
mutat
call
synthet
lethal
analysi
sl
power
tool
understand
genet
interact
essenti
metabol
pathway
synthet
lethal
extens
use
studi
gene
product
interact
secret
pathway
yeast
bacteria
even
identifi
anticanc
agent
notic
mani
case
doubl
mutant
identifi
coleth
mutat
differ
gene
yeast
studi
analyz
protein
structurefunct
aspect
reveal
intragen
synthet
lethal
ie
case
coleth
mutat
occur
one
gene
littl
sl
research
undertaken
virus
research
rather
quest
opposit
situat
one
crippl
mutat
rescu
second
intragen
suppressor
mutat
second
restor
function
lost
due
first
mutat
also
found
underrepres
intragen
suppressor
actual
turn
sl
line
patent
model
chose
focu
intragen
synthet
lethal
hiv
proteas
mention
number
replicativitycrit
amino
acid
avail
drug
dock
maxim
invari
amino
acid
numer
enough
one
singl
sl
coupl
possibl
littl
propos
add
larger
sl
set
rather
one
singl
sl
coupl
sl
set
mean
set
sl
coupl
connect
choos
add
also
invari
posit
vicin
sl
set
inde
set
posit
contain
invari
amino
acid
plu
sl
set
may
larg
enough
target
put
antivir
drug
test
antiescap
approach
practic
studi
proteas
b
subtyp
protein
amino
acid
homodimer
aspart
proteas
substratebind
pocket
includ
catalyt
triad
flap
region
presum
open
close
allow
entri
bind
substrat
inhibitor
protein
variant
posit
first
align
amino
acid
sequenc
hiv
proteas
align
determin
coupl
posit
statist
never
found
mutat
togeth
call
sl
focus
sl
set
access
solvent
far
apart
spatial
report
method
yield
target
respect
amino
acid
unlik
current
document
drug
target
mutat
escap
drug
treatment
target
conserv
otherwis
viral
replic
would
suffer
impair
viral
pathogen
gener
process
cours
use
hiv
protein
rna
virus
highli
variabl
agent
first
step
defin
coupl
proteas
posit
synthet
lethal
analyz
patient
proteas
amino
acid
sequenc
subtyp
b
patient
previous
treat
antivir
drug
never
pool
sequenc
appropri
repres
actual
viral
divers
kept
sequenc
one
set
four
differ
reason
firstli
untreat
patient
get
viral
sequenc
possibl
highli
mutat
treat
patient
secondli
treatment
select
pressur
pressur
select
mutat
appear
treat
untreat
set
thirdli
dataset
enrich
plenti
mutat
unknown
patient
unknown
treatment
histori
final
want
creat
tool
robust
enough
use
rna
viru
databas
less
document
hiv
sequenc
occur
multipl
copi
sequenc
collect
kept
redund
copi
assum
redund
may
reflect
biolog
fit
mostli
ident
copi
differ
patient
rather
multipl
sampl
patient
use
clonal
data
less
inform
enough
sequenc
mutat
enough
sequenc
align
align
found
posit
display
chang
less
sequenc
call
posit
invari
ceccherinisilberstein
et
al
defin
invari
posit
display
chang
less
sequenc
found
posit
invari
posit
total
includ
ceccherinisilberstein
invari
set
proteas
inhibitor
pi
treat
patient
stanford
univers
hiv
drug
resist
databas
describ
posit
repres
less
hiv
subtyp
b
sequenc
pi
treat
patient
invari
posit
also
includ
group
invari
posit
set
asid
momentarili
compar
variant
posit
pair
coupl
detect
sl
coupl
first
examin
distribut
pvalu
test
associ
coupl
use
fals
discoveri
rate
fdr
threshold
identifi
synthet
lethal
coupl
coupl
span
proteas
posit
remain
posit
repres
coupl
name
total
sl
graph
made
node
repres
proteas
posit
edg
repres
relat
coleth
link
synthet
lethal
posit
data
shown
three
team
use
differ
method
inform
theori
chi
studi
bayesian
network
identifi
coupl
hiv
proteas
coevolv
posit
amongst
result
found
synthet
lethal
coupl
around
although
unlik
team
discrimin
proteas
treat
versu
nontreat
patient
collect
initi
lot
sequenc
sl
coupl
includ
sl
coupl
none
includ
sl
set
method
therefor
enabl
us
find
coupl
alreadi
describ
team
use
method
distanc
two
posit
coupl
calcul
use
proteas
structur
pdb
result
distanc
graph
superimpos
total
sl
graph
access
put
drug
amino
acid
fulfil
two
precondit
spatial
close
enough
possibl
form
pocket
structur
solventaccess
outsid
protein
thu
chose
retain
cluster
close
posit
keep
edg
indic
less
distanc
two
node
result
drastic
reduc
graph
spatial
close
sl
shown
figur
go
node
spatial
close
sl
graph
select
solvent
access
posit
shown
figur
shade
oval
visibl
cluster
contain
interlink
expos
posit
box
figur
encompass
node
shown
color
orang
red
yellow
oval
edg
black
continu
line
separ
intraconnect
subgraph
sg
sl
set
refer
sgflap
node
shown
orang
oval
sgcanti
node
red
node
yellow
node
yellow
combin
plu
name
sgfulc
name
given
retrospect
remind
specif
region
proteas
structur
name
sgflap
includ
posit
found
proteas
flap
sgcanti
includ
posit
found
proteas
cantilev
posit
sgfulc
proteas
fulcrum
subgraph
part
catalyt
site
cluster
identifi
complement
neighbor
access
invari
antiproteas
drug
activ
dock
must
block
vital
proteas
function
compromis
viral
escap
dock
invari
posit
sl
set
describ
materi
method
kept
invari
posit
asid
obvious
lethal
search
synthet
lethal
invari
posit
cours
prime
target
candid
dock
antivir
agent
limit
escap
possibl
ad
invari
posit
shown
green
rectangl
shade
blue
figur
access
close
lock
set
shown
oval
figur
addit
invari
obtain
lock
set
much
less
escapepron
much
lock
quantifi
rank
graph
term
closer
maxim
cliqu
brought
defin
connect
coeffici
c
materi
method
c
vari
graph
edg
graph
possibl
edg
node
present
ie
maxim
cliqu
closer
c
least
escapepron
group
full
figur
graph
node
edg
black
plu
implicit
edg
link
invari
posit
other
sake
clariti
implicit
link
within
distanc
repres
dot
green
line
sgflap
includ
larger
connect
subgraph
name
sgiflap
edg
includ
black
dot
line
implicit
edg
figur
connect
coeffici
increas
c
sgflap
c
sgiflap
sgiflap
invari
amino
acid
within
within
whole
sgflap
residu
within
sgflap
residu
whole
sgiflap
set
interest
result
sinc
amino
acid
access
ca
nt
freeli
mutat
without
damag
replic
close
enough
space
imagin
design
singl
drug
target
sever
figur
show
amino
acid
dimer
structur
use
color
code
figur
four
orang
sl
three
green
invari
import
note
posit
bear
indispens
viral
function
name
mutat
posit
provok
total
loss
proteas
activ
mutat
either
posit
provok
drop
proteas
activ
variant
analyz
martinez
et
al
mutat
posit
display
averag
drop
proteas
activ
vs
wild
doubl
mutant
replic
poorli
import
piec
inform
us
sinc
report
posit
sl
cf
next
paragraph
look
sgfulc
yield
complementari
target
recommend
sgfulc
amino
acid
interest
link
sl
well
invari
latter
close
sgfulc
posit
happen
less
shown
furthermor
distanc
taken
account
amino
acid
maxim
cliqu
one
may
found
mutat
overal
identifi
cluster
amino
acid
connect
coeffici
c
sgifulc
close
amongst
two
may
freeli
mutat
set
call
sgifulc
therefor
good
target
put
drug
figur
interest
note
posit
secondari
mutat
confer
resist
mutat
posit
occur
often
treat
patient
drugnaiv
patient
lock
target
describ
actual
druggabl
pocket
studi
use
qsitefind
softwar
program
univers
leed
qsitefind
take
structur
input
output
top
ligandbind
site
two
ligandbind
site
proteas
overlap
lock
target
sgiflap
sgifulc
five
seven
posit
sgiflap
pocket
one
site
defin
qsitefind
three
five
posit
sgifulc
pocket
one
site
defin
qsitefind
amino
acid
first
lock
target
subgraph
sgiflap
figur
part
proteas
flap
extern
loop
flap
mobil
structur
open
let
substrat
pass
one
imagin
molecul
drugdesign
bind
extern
loop
proteas
flap
could
block
mobil
therefor
keep
figur
spatial
close
sl
whole
graph
repres
spatial
close
sl
blueshad
oval
repres
access
spatial
close
sl
oval
contain
amino
acid
onelett
codenam
found
proteas
ancestr
sequenc
follow
posit
sequenc
access
residu
shade
blue
black
edg
link
node
mean
coleth
within
ing
proteas
process
substrat
idea
also
develop
perryman
et
al
use
molecular
dynam
also
propos
affect
flap
mobil
approach
agreement
believ
group
good
candid
futur
drug
target
method
describ
manuscript
enabl
us
defin
aminoacid
would
adequ
drug
target
limit
avoid
escap
method
tell
us
whether
aminoacid
defin
actual
druggabl
pocket
check
use
qsitefind
softwar
take
structur
protein
input
output
ligandbind
site
sl
lock
target
describ
sgiflap
sgifulc
close
overlap
two
site
reveal
qsitefind
hiv
proteas
respect
posit
result
suggest
sl
lock
target
sgiflap
sgifulc
actual
druggabl
pocket
sinc
result
use
ancestr
sequenc
start
point
relev
methodolog
control
would
check
whether
result
stand
anoth
accept
start
point
sequenc
use
use
method
histor
refer
medic
studi
hivlaicg
sequenc
see
method
instead
ancestr
sequenc
result
smaller
graph
shown
equal
figur
subgraph
sgcanti
sgfulc
plu
amino
acid
believ
approach
complementari
support
mutual
control
sinc
recommend
target
sgcanti
sgfulc
conserv
great
extent
gener
standpoint
seem
obviou
differ
branch
one
phylogenet
tree
specif
synthet
lethal
synthet
lethal
mix
sinc
usabl
target
relev
phylogenet
branch
case
three
main
branch
group
n
branch
subgroup
divid
subgroup
includ
subgroup
b
choos
work
subgroup
b
publish
sequenc
proteas
mutat
although
simpl
algorithm
today
build
tree
ten
thousand
sequenc
would
interest
studi
phylogen
tree
pool
sequenc
parallel
synthet
lethal
studi
howev
evolutionari
point
view
believ
posit
coevolut
two
site
posit
alway
mutat
togeth
issu
exclus
coevolut
posit
mutat
never
togeth
inde
examin
propag
mutat
posit
tree
two
situat
distinguish
either
copres
major
subtre
tend
indic
nois
sinc
segreg
copres
leav
one
part
tree
tend
indic
true
coevolut
invers
studi
case
exclus
coevolut
one
two
situat
possibl
inde
definit
synthet
lethal
mutat
part
subtre
sinc
copres
lethal
tree
result
situat
imposs
analyz
sinc
one
analyz
subtre
order
find
miss
branch
correspond
statist
studi
conduct
method
treat
variat
posit
biallel
mutat
versu
nonmut
genotyp
arguabl
would
seem
inform
take
account
actual
aminoacid
chang
would
entail
choos
score
matrix
score
matrix
take
account
physicochem
specif
aminoacid
decid
whether
mutat
one
similar
initi
one
mutat
involv
resist
antiproteas
drug
follow
rule
therefor
think
use
exist
score
matrix
blosum
pam
type
would
inform
final
fact
synthet
lethal
comut
never
observ
statist
mean
comut
complet
imposs
henc
use
express
potenti
sl
case
experiment
replic
data
result
inde
includ
case
synthet
lethal
actual
mutat
although
occur
less
sequenc
data
shown
sequenc
truli
repres
replic
virus
figur
box
colour
code
link
black
edg
black
edg
mean
coleth
within
correspond
pvalu
shown
edg
invari
amino
acid
box
green
link
dot
green
edg
mean
within
node
shade
blue
access
invari
also
link
node
implicit
edg
shown
sake
clariti
lock
target
repres
subgraph
call
sgi
flap
orangegreen
lock
target
repres
subgraph
b
call
sgi
canti
redgreen
lock
target
repres
subgraph
c
call
sgi
fulc
yellowgreen
graph
built
use
graphviz
softwar
oppos
unfilt
artifact
risk
block
synthet
lethal
coupl
new
drug
could
creat
select
bottleneck
forc
viral
evolut
toward
resist
strain
new
escap
mutant
appear
care
monitor
sequenc
least
synthet
lethal
posit
first
step
refin
antivir
strategi
case
method
advantag
indic
comprehens
list
possibl
proteas
lock
target
best
target
minim
elimin
viral
escap
even
lockedsetdesign
antivir
drug
somehow
elicit
escap
mutant
nonlock
amino
acid
would
remain
wrong
target
sinc
viral
escap
seem
nearli
guarante
correspond
multimut
hiv
alreadi
natur
sequenc
worldwid
databank
constant
rise
drug
resist
rna
virus
reason
start
look
therapeut
strategi
minim
elimin
viral
escap
describ
method
identifi
target
may
involv
essenti
viral
function
call
lock
target
spatial
close
access
viral
invari
posit
andor
potenti
synthet
lethal
sl
group
surviv
mutat
lethal
whenev
two
cooccur
due
two
featur
vital
function
invari
target
uniqu
might
minim
prevent
viral
escap
applic
hiv
proteas
yield
lock
target
access
compact
enough
possibl
dock
drug
outsid
enzym
activ
site
wherea
date
exist
antiproteas
drug
competit
inhibitor
bind
activ
site
first
lock
target
close
made
amino
acid
posit
proteas
flap
cantilev
second
lock
target
detect
made
amino
acid
proteas
fulcrum
third
lock
target
compos
amino
acid
locat
proteas
cantilev
region
three
lock
target
altogeth
contain
proteas
amino
acid
posit
biolog
evid
regard
posit
provid
result
section
support
lock
target
strateg
drug
target
seem
viru
easili
mutat
target
escap
statist
significantli
exclud
free
comut
within
target
method
made
priori
assumpt
posit
sequenc
set
reveal
lock
target
bear
essenti
biolog
function
valid
start
hypothesi
link
sl
essenti
biolog
function
believ
method
use
variabl
protein
identif
best
lock
target
obvious
approach
describ
use
gene
also
virus
hcv
sarscov
influenza
inde
quickli
variabl
protein
sequenc
larg
sequenc
bank
need
statist
exist
alreadi
expand
quickli
due
speed
improv
mass
sequenc
technolog
pol
gene
code
three
protein
proteas
revers
transcriptas
rt
integras
contain
respect
amino
acid
pool
amino
acid
sequenc
whole
partial
subtyp
b
pol
three
databas
swissprot
lo
alamo
nation
librari
stanford
univers
hiv
drug
resist
databas
thu
collect
pol
sequenc
patient
treat
non
treat
unknown
treatment
histori
use
refer
amino
acid
align
proteas
download
lo
alamo
nation
librari
built
profil
hmmer
packag
use
hmmbuild
hmmcalibr
function
sequenc
first
kept
least
ctermin
proteas
motif
pqvtlw
least
ntermin
proteas
motif
gctlnf
new
set
sequenc
align
abovement
profil
result
align
use
order
creat
new
accur
profil
align
small
sequenc
collect
initi
set
partial
sequenc
amino
acid
neither
ctermin
ntermin
motif
least
ident
new
profil
partial
sequenc
align
new
accur
profil
final
align
remov
sequenc
show
insert
obtain
one
set
proteas
sequenc
amongst
proteas
sequenc
sequenc
repres
frequent
sequenc
repres
time
sequenc
full
length
contain
posit
proteas
order
label
posit
mutat
wild
type
need
refer
sequenc
first
comput
consensu
proteas
sequenc
attempt
use
refer
sequenc
misleadingli
label
wild
type
extrem
frequent
mutat
discard
choic
refer
histor
refer
medic
studi
hivlaicg
genbank
first
sequenc
ever
publish
hivlaicg
though
root
phylogen
tree
repres
sequenc
root
ancestr
sequenc
phylogenet
comput
subtyp
b
sequenc
often
refer
biocomput
studi
observ
set
mutat
defin
hivlaicg
ancestr
sequenc
nearli
ident
data
shown
addit
two
posit
differ
two
sequenc
posit
n
ancestr
sequenc
versu
hivlaicg
k
versu
r
respect
overal
argument
made
us
opt
choic
ancestr
sequenc
refer
control
purpos
also
tri
use
hivlaicg
refer
separ
experi
yield
similar
result
algorithm
proceed
follow
align
obtain
protein
sequenc
first
posit
compar
first
posit
refer
sequenc
determin
whether
mutat
posit
mutat
refer
recod
conserv
one
process
iter
second
posit
end
sequenc
thu
sequenc
recod
seri
got
matrix
box
contain
either
avoid
mistak
sequenc
error
mutat
actual
invari
amino
acid
posit
set
asid
posit
display
chang
less
sequenc
cutoff
chosen
percentag
mutat
measur
within
three
amino
acid
around
activ
site
throughout
databas
use
threshold
found
posit
display
chang
less
sequenc
refer
invari
focus
posit
matrix
chose
test
evalu
mutual
independ
posit
order
extract
set
coupl
potenti
synthet
lethal
compar
pair
posit
column
first
matrix
note
result
matrix
matrix
conting
tabl
contain
four
element
number
mutat
mutat
repres
column
compar
first
matrix
number
nonmut
nonmut
number
mutat
nonmut
number
nonmut
mutat
null
hypothesi
posit
independ
use
number
perform
time
onedegreeoffreedom
test
associ
pvalu
calcul
coupl
posit
sinc
multipl
test
order
compar
pvalu
result
decid
whether
result
signific
studi
distribut
pvalu
use
benjaminihochberg
storey
method
comput
fals
discoveri
rate
fdr
associ
differ
pvalu
alpha
risk
class
vari
alpha
risk
class
repres
comput
count
associ
pvalu
built
associ
histogram
final
fdr
associ
alpha
risk
comput
follow
formula
n
total
number
pvalu
calcul
nb
class
count
associ
final
kept
coupl
pvalu
fdr
lower
posit
coupl
therefor
statist
depend
pair
statist
depend
coupl
order
defin
synthet
lethal
focus
posit
observ
number
mutatednon
mutat
non
mutatedmut
coupl
greater
theoret
expect
number
two
posit
mutat
independ
singl
coupl
posit
statist
mutat
less
often
togeth
would
expect
random
behavior
statist
depend
posit
refer
relat
seem
synthet
lethal
indiffer
seem
coleth
coupl
call
sl
follow
keep
mind
formal
call
potenti
sl
biolog
data
demonstr
actual
coleth
order
defin
access
amino
acid
put
extern
ligand
futur
drug
mind
use
proteas
structur
pdb
comput
surfac
access
solvent
use
asa
softwar
avail
rpb
consid
access
amino
acid
access
threshold
greater
set
element
eg
amino
acid
link
relat
repres
graph
graph
design
studi
one
node
proteas
amino
acid
posit
graph
edg
bear
relat
coleth
call
n
number
node
graph
minim
number
edg
min
maxim
number
edg
graph
reach
maximum
number
edg
ie
node
interlink
two
two
call
maxim
cliqu
properti
import
screen
sl
within
maxim
cliqu
one
amino
acid
may
mutat
freeli
second
mutat
lethal
determin
maxim
cliqu
contain
graph
use
program
eric
coissac
person
commun
sl
set
maxim
cliqu
sl
set
quit
close
maxim
cliqu
want
determin
degre
connect
graph
defin
c
ob
observ
number
edg
graph
closer
c
closer
graph
maxim
cliqu
set
lock
one
mutat
possibl
without
lethal
invers
valu
close
indic
posit
consid
may
mutat
without
lethal
set
lock
even
sl
set
plain
set
amino
acid
posit
whenev
node
invari
amino
acid
definit
link
node
inde
add
invari
sl
set
order
extend
target
lock
set
lock
set
mean
sl
set
plu
invari
posit
inde
set
posit
contain
invari
amino
acid
plu
sl
set
may
larg
enough
target
put
antivir
drug
call
conserv
posit
lock
ca
nt
escap
freeli
mutat
invari
total
lock
mutat
surviv
sl
set
partial
lock
mutat
combin
surviv
n
invari
node
ad
graph
node
alreadi
link
ob
edg
new
connect
coeffici
c
connect
gain
invari
ad
sl
set
quantifi
increas
c
c
review
report
review
amushegian
stower
institut
kansa
citi
unit
state
manuscript
brouillet
coauthor
present
simpl
direct
opinion
promis
strategi
toward
comput
select
druggabl
target
base
infer
intramolecular
synthet
lethal
pair
amino
acid
substitut
clearli
written
major
concern
technic
side
work
howev
addit
explan
follow
would
help
author
present
reason
includ
data
except
incomplet
suspectederron
sequenc
reason
compel
enough
yet
wonder
whether
data
bias
way
assign
synthet
lethal
chang
dataset
made
nonredund
sampl
total
dataset
repeatedli
control
inde
use
dataset
nonredund
proteas
sequenc
determin
sl
set
deduc
lock
target
three
lock
target
found
fewer
posit
correspond
sgiflap
constitut
sgiflap
posit
except
posit
sgicanti
also
constitut
posit
except
posit
sgifulc
lost
posit
sinc
much
differ
use
popul
repres
biolog
fit
explain
manuscript
relat
issu
applic
method
molecul
author
indic
enough
sequenc
anoth
viru
databas
newgener
sequenc
method
may
come
rescu
sequenc
mani
read
enough
properti
sampl
might
predict
success
approach
believ
formula
comput
minimum
number
sequenc
necessari
determin
sl
coupl
given
protein
depend
unknown
count
coupl
hand
chi
test
impos
theoret
count
cell
conting
tabl
greater
pair
posit
studi
actual
sl
coupl
take
least
sequenc
compli
condit
number
sl
coupl
cours
initi
unknown
perhap
simul
repetit
experi
histor
data
hiv
year
dataset
sequenc
strategi
first
time
made
syntheticleth
pair
visibl
use
method
may
provid
guidanc
declar
compet
interest
review
shamil
sunyaev
harvard
medic
school
boston
unit
state
interest
manuscript
molecular
evolut
structur
analysi
hiv
proteas
goal
studi
use
coevolut
amino
acid
pair
propos
drug
bind
site
immun
mutat
escap
although
work
interest
comment
list
approach
base
conting
tabl
analysi
ignor
phylogenet
structur
dataset
may
lead
falseposit
predict
coevolv
residu
clear
size
dataset
prevent
accur
phylogenet
analysi
howev
easier
verifi
select
cluster
explain
phylogeni
repres
real
signal
coevolut
least
manuscript
would
benefit
detail
discuss
point
read
suggest
interest
howev
appear
imposs
execut
describ
experi
due
number
sequenc
dataset
sequenc
idea
limit
phylogenet
studi
select
cluster
interest
still
evolutionari
point
view
believ
posit
coevolut
two
site
posit
alway
mutat
togeth
issu
exclus
coevolut
posit
mutat
never
togeth
inde
examin
propag
mutat
posit
tree
two
situat
distinguish
either
copres
major
subtre
tend
indic
nois
sinc
segreg
copres
leav
one
part
tree
tend
indic
true
coevolut
invers
studi
case
exclus
coevolut
one
two
situat
possibl
inde
definit
synthet
lethal
mutat
part
subtre
sinc
copres
lethal
tree
result
situat
imposs
analyz
sinc
one
analyz
subtre
order
find
miss
branch
correspond
statist
studi
conduct
includ
paragraph
discuss
section
unclear
method
treat
variat
posit
biallel
mutat
nonmut
genotyp
possibl
take
account
actual
amino
acid
type
would
inform
point
warrant
least
detail
discuss
ye
total
agre
also
thought
issu
address
need
choos
score
matrix
score
matrix
take
account
physicochem
specif
aminoacid
decid
whether
mutat
one
similar
initi
one
mutat
involv
resist
antiproteas
drug
follow
rule
inde
resist
due
mutat
one
aminoacid
anoth
one
close
physicochem
characterist
therefor
think
use
score
matrix
blosum
pam
type
would
inform
includ
paragraph
discuss
section
manuscript
would
benefit
clarif
main
hypothesi
would
singl
mutat
sl
cluster
alway
insuffici
effici
escap
review
comment
one
major
concern
definit
synthet
lethal
though
author
identifi
basi
test
associ
null
hypothesi
test
frequenc
site
mutat
product
frequenc
individu
site
mutat
deviat
null
hypothesi
howev
small
produc
signific
result
number
observ
suffici
larg
thu
site
b
slightli
less
like
mutat
site
mutat
author
procedur
would
predict
b
synthet
lethal
pair
even
though
fit
cost
mutat
b
may
minut
claim
chi
test
larg
sampl
detect
smallest
depend
sinc
check
fals
discoveri
rate
produc
tabl
pvalu
determin
valid
chi
test
pvalu
appear
figur
seem
better
way
defin
synthet
lethal
search
pair
site
never
mutat
togeth
ie
frequenc
pair
threshold
sequenc
error
suspect
though
pair
exceedingli
rare
second
concern
method
present
paper
consid
effect
evolutionari
histori
well
known
phylogenet
relationship
produc
appar
nonindepend
site
method
control
effect
exist
could
use
place
author
method
see
eg
noivirt
eisenstein
horovitz
detect
reduct
evolutionari
nois
correl
mutat
analysi
protein
eng
de
sel
read
articl
interest
unfortun
seem
imposs
execut
experi
describ
number
sequenc
dataset
larg
sequenc
furthermor
evolutionari
point
view
believ
posit
coevolut
two
site
posit
alway
mutat
togeth
issu
exclus
coevolut
posit
mutat
never
togeth
inde
examin
propag
mutat
posit
tree
two
situat
distinguish
either
copres
major
subtre
tend
indic
nois
sinc
segreg
copres
leav
one
part
tree
tend
indic
true
coevolut
invers
studi
case
exclus
coevolut
one
two
situat
possibl
inde
definit
synthet
lethal
mutat
part
subtre
sinc
copres
lethal
tree
result
situat
imposs
analyz
sinc
one
analyz
subtre
order
find
miss
branch
correspond
statist
studi
conduct
includ
paragraph
discuss
section
review
clau
wilk
univers
texa
center
comput
biolog
institut
cell
molecular
biolog
austin
texa
unit
state
author
use
concept
coleth
mutat
identifi
possibl
drug
target
hiv
two
major
comment
concern
definit
synthet
lethal
author
identifi
basi
test
associ
null
hypothesi
test
frequenc
site
mutat
product
frequenc
individu
site
mutat
deviat
null
hypothesi
howev
small
produc
signific
result
number
observ
suffici
larg
thu
site
b
slightli
less
like
mutat
site
mutat
author
procedur
would
predict
b
synthet
lethal
pair
even
though
fit
cost
mutat
b
may
minut
method
present
paper
control
effect
evolutionari
histori
well
known
phylogenet
relationship
produc
appar
nonindepend
site
method
control
effect
exist
could
use
place
author
method
see
eg
noivirt
eisenstein
horovitz
detect
reduct
evolutionari
nois
correl
mutat
analysi
protein
eng
de
sel
author
argu
data
set
larg
control
phylogeni
may
case
nt
alter
fact
data
set
like
confound
phylogeni
tion
help
draft
manuscript
tv
help
studi
design
provid
comment
feedback
draft
manuscript
translat
english
eo
creat
databas
involv
draft
manuscript
lm
provid
help
statist
sl
coupl
analysi
av
carri
concept
design
coordin
analysi
interpret
sl
coupl
lock
set
wrote
draft
manuscript
gave
final
approv
version
publish
author
read
approv
final
manuscript
